Close mobile menu×
Close mobile menu

Andrei Constantinescu, MD, PhD

Board Certifications: 
Pediatric Pulmonology, Pediatrics
Accepting New Patients
Treats Children
Profile Hero

Appointments

Phone Appointments

New and Existing Patients: 

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Pediatric Pulmonology
  • Pediatrics

Clinical Expertise

  • Pediatric Bronchoscopy
  • Pediatric Pulmonology
  • Pediatric Pulmonary Medicine
  • Pediatric Pulmonary Diseases
  • Pediatric Asthma
  • Ventilator Dependency
  • Transplant Pulmonology
  • Cystic Fibrosis
  • Neuromuscular Disease
  • Non-Invasive Mechanical Ventilation
  • Respiratory Failure
  • Asthma

Education & Training

  • Johns Hopkins University School of Medicine
  • Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: Morgan Stanley Children's Hospital of NewYork-Presbyterian

About Andrei Constantinescu

Dr. Constantinescu has an active clinical practice at Columbia University Medical Center, including care of children with asthma, cystic fibrosis, and technology-dependent conditions (home ventilation by invasive and non-invasive means, mechanically assisted airway clearance, etc.) He participates in the Muscular Dystrophy Clinic at Columbia, for the management of pulmonary complications of neuromuscular disorders. Through the multidisciplinary Motor Neuron Center at Columbia, Dr. Constantinescu is also involved in clinical research in the area of pulmonary function in neuromuscular disease.

Academic Titles

  • Assistant Professor of Pediatrics at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • French
  • Romanian

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Anthem Blue Cross Blue Shield

  • Anthem Blue Cross Blue Shield

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

Research

Grants

A PHASE 3, OPEN-LABEL, ROLLOVER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH TAZACAFFOR IN COMBINATION WITH TIVACAFTOR IN SUBJECTS WITH CYSTIC FIBROSYS AGED 6 YEARS AND OLDER, MOMOZYGOUS OR HETEROZYGOUS FOR THE F508DEL-CFTR MUTAT (P&S Industry Clinical Trial)

Sep 11 2018 - Sep 11 2023

A PHASE 2 RANDOMIZED, COUBLE-BLIND,PLACEBO CONTROLLED REPEAT DOSE STUDY OF KB001-A IN SUBJECTS WITH CYCTIC FIBROSIS INFECTED WITH PSEUDONOMAS AERUOGINOSA (P&S Industry Clinical Trial)

Jul 11 2013 - Jul 11 2018

SMA FOUNDATION CENTER GRANT (Private)

Jul 1 2015 - Jun 30 2018

SPINAL MUSCULAR ATROPHY ASSOCIATION PROPOSAL (Private)

Jan 1 2006 - Mar 31 2018

CF CENTER RENEWAL 2015-2016 (Private)

Jul 1 2015 - Jun 30 2016

SMA FOUNDATION CENTER GRANT (Private)

Jul 1 2015 - Dec 31 2015

PEDIATRIC NEUROMUSCULAR CLINICAL RESEARCH NETWORK FOR SMA (Private)

Jul 1 2012 - Jun 30 2015

COLUMBIA UNIVERSITY THERAPEUTICS DEVELOPMENT CENTER (Private)

Jan 1 2009 - Dec 31 2013

PEDIATRIC NEUROMUSCULAR CLINICAL RESEARCH (Private)

Jul 1 2004 - Jun 30 2012

PEDIATRIC NEUROMUSCULAR CLINICAL RESEARCH NETWORK (Private)

Jul 1 2004 - Jun 30 2012

PEDIATRIC NEUROMUSCULAR CLINICAL RESEARCH NETWORK FOR SPINAL MUSCULAR ATROPHY CLINICAL TRIALS (Private)

Jul 1 2004 - Jun 30 2012

COLUMBIA UNIVERSITY SPINAL MUSCULAR ATROPHY (SMA) RESEARCH P ROGRAM (Federal Gov)

Jan 1 2008 - Jul 31 2011